연구성과로 돌아가기

2022 연구자 정보 (69 / 1074)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Cabreros, Carlo
(Cabreros, C) ⓘ 		Univ Philippines, Natl Grad Sch Engn, Environm Engn Program, 1101 Diliman, Quezon City, Philippines ⓘ
ⓘ 		0000-0003-1695-0564
Cabreros, Carlo ⓘ 		[JCR상위 2.7] Occurrence, transformation, bioaccumulation, risk and analysis of pharmaceutical and personal care products from wastewater: a review ⓘ SCIE ⓘ 2.7 CHEMISTRY, MULTIDISCIPLINARY;ENGINEERING, ENVIRONMENTAL;ENVIRONMENTAL SCIENCES ⓘ ushuats@gmail.com;elza.bontempi@unibs.it; ⓘ
Cameron, David A.
(Cameron, DA) ⓘ 		Univ Edinburgh, Inst Genet & Canc, Edinburgh Canc Ctr, Edinburgh, Scotland ⓘ C-7781-2013
Cameron, David ⓘ 		0000-0002-2717-7979
Cameron, David ⓘ 		[JCR상위 2.7] Trastuzumab deruxtecan (T-DXd) versus treatment of physician's choice (TPC) in patients (pts) with HER2-low unresectable and/or metastatic breast cancer (mBC): Results of DESTINY-Breast04, a randomized, phase 3 study.
[JCR상위 0.9] Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer ⓘ 		SCIE ⓘ 0.9 ONCOLOGY
MEDICINE, GENERAL & INTERNAL ⓘ 		modis@mskcc.org; ⓘ
Choi, Gyu Seog
(Choi, GS) ⓘ 		Kyungpook Natl Univ, Kyungpook Natl Univ Med Ctr, Colorectal Canc Ctr, Sch Med, Daegu, South Korea
Kyungpook Natl Univ, Kyungpook Natl Univ Chilgok Hosp, Sch Med, Dept Surg, Daegu, South Korea
Kyungpook Natl Univ, Med Ctr, Colorectal Canc Ctr, Sch Med, Daegu, South Korea
Kyungpook Natl Univ, Sch Med, Med Ctr, Colorectal Canc Ctr, Daegu, South Korea ⓘ
ⓘ 		0000-0001-5476-4610
Choi, Gyu-Seog ⓘ 		[JCR상위 2.7] Clinical implication of KRAS mutation variants in patients with resected colon cancer
[JCR상위 16.2] ASO Author Reflections: Toward the Prediction of Peritoneal Recurrence After Curative Resection for Colon Cancer
Clinical implication of adjuvant chemotherapy according to mismatch repair status in patients with intermediate-risk stage II colon cancer: a retrospective study
[JCR상위 14.8] Does laparoscopy increase the risk of peritoneal recurrence after resection for pT4 colon cancer? Results of a propensity score-matched analysis from an international cohort
[JCR상위 16.2] ASO Visual Abstract: Prediction of Metachronous Peritoneal Metastases After Radical Surgery for Colon Cancer: A Scoring System Obtained from an International Multicenter Cohort
[JCR상위 16.2] Prediction of Metachronous Peritoneal Metastases After Radical Surgery for Colon Cancer: A Scoring System Obtained from an International Multicenter Cohort
[JCR상위 18.1] Laparoscopic versus open surgery for left flexure colon cancer: A propensity score matched analysis from an international cohort ⓘ 		SCIE ⓘ 2.7 ONCOLOGY
ONCOLOGY;SURGERY
GASTROENTEROLOGY & HEPATOLOGY;SURGERY ⓘ 		corrado.pedrazzani@univr.it;
jhbaek@knu.ac.kr;jkk21c@knu.ac.kr;
corrado.pedrazzani@univr.it;chocogom@hanmail.net;camp79@yuhs.ac;giulia.turri89@gmail.com;gaia.zagolin@gmail.com;caterina.foppa@humanitas.it;whitenoja@yuhs.ac;gaya.spolverato@gmail.com;antonino.spinelli@hunimed.eu;kyuschoi@knu.ac.kr; ⓘ
Choi, Jinhyuk
(Choi, J) ⓘ 		제1저자 Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 2.7] Estrogen-Related Receptor γ Maintains Pancreatic Acinar Cell Function and Identity by Regulating Cellular Metabolism ⓘ SCIE ⓘ 2.7 GASTROENTEROLOGY & HEPATOLOGY ⓘ eiji.yoshihara@lundquist.org;evans@salk.edu;jmsuh@kaist.ac.kr; ⓘ
Dey, Abhijit
(Dey, A) ⓘ 		Presidency Univ, Dept Life Sci, 86-1 Coll St, Kolkata 700073, W Bengal, India ⓘ AAG-2439-2020
Dey, Abhijit ⓘ
ⓘ 		[JCR상위 2.7] Occurrence, transformation, bioaccumulation, risk and analysis of pharmaceutical and personal care products from wastewater: a review ⓘ SCIE ⓘ 2.7 CHEMISTRY, MULTIDISCIPLINARY;ENGINEERING, ENVIRONMENTAL;ENVIRONMENTAL SCIENCES ⓘ ushuats@gmail.com;elza.bontempi@unibs.it; ⓘ
Downes, Michael
(Downes, M) ⓘ 		Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA ⓘ
ⓘ
ⓘ 		[JCR상위 2.7] Estrogen-Related Receptor γ Maintains Pancreatic Acinar Cell Function and Identity by Regulating Cellular Metabolism
[JCR상위 0.7] Obesity alters pathology and treatment response in inflammatory disease ⓘ 		SCIE ⓘ 0.7 GASTROENTEROLOGY & HEPATOLOGY
MULTIDISCIPLINARY SCIENCES ⓘ 		eiji.yoshihara@lundquist.org;evans@salk.edu;jmsuh@kaist.ac.kr;
sagar.bapat@ucsf.edu;evans@salk.edu;yzheng@salk.edu;alexander.marson@ucsf.edu; ⓘ
Evans, Ronald M.
(Evans, RM) ⓘ 		교신저자 Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA ⓘ AAF-4001-2019
Evans, Ronald ⓘ
ⓘ 		[JCR상위 2.7] Estrogen-Related Receptor γ Maintains Pancreatic Acinar Cell Function and Identity by Regulating Cellular Metabolism
[JCR상위 0.7] Obesity alters pathology and treatment response in inflammatory disease ⓘ 		SCIE ⓘ 0.7 GASTROENTEROLOGY & HEPATOLOGY
MULTIDISCIPLINARY SCIENCES ⓘ 		eiji.yoshihara@lundquist.org;evans@salk.edu;jmsuh@kaist.ac.kr;
sagar.bapat@ucsf.edu;evans@salk.edu;yzheng@salk.edu;alexander.marson@ucsf.edu; ⓘ
Fan, Weiwei
(Fan, WW) ⓘ 		Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA ⓘ GXZ-9902-2022
Frank, Viki ⓘ
ⓘ 		[JCR상위 2.7] Estrogen-Related Receptor γ Maintains Pancreatic Acinar Cell Function and Identity by Regulating Cellular Metabolism ⓘ SCIE ⓘ 2.7 GASTROENTEROLOGY & HEPATOLOGY ⓘ eiji.yoshihara@lundquist.org;evans@salk.edu;jmsuh@kaist.ac.kr; ⓘ
Gambhire, Dhiraj
(Gambhire, D) ⓘ 		Daiichi Sankyo, Basking Ridge, NJ USA ⓘ
ⓘ
ⓘ 		[JCR상위 2.7] Trastuzumab deruxtecan (T-DXd) versus treatment of physician's choice (TPC) in patients (pts) with HER2-low unresectable and/or metastatic breast cancer (mBC): Results of DESTINY-Breast04, a randomized, phase 3 study.
[JCR상위 0.9] Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer ⓘ 		SCIE ⓘ 0.9 ONCOLOGY
MEDICINE, GENERAL & INTERNAL ⓘ 		modis@mskcc.org; ⓘ
Goodarzi, Mark O.
(Goodarzi, MO) ⓘ 		Cedars Sinai Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Los Angeles, CA 90048 USA ⓘ AAH-7106-2021
Goodarzi, Mark ⓘ
ⓘ 		[JCR상위 2.7] Estrogen-Related Receptor γ Maintains Pancreatic Acinar Cell Function and Identity by Regulating Cellular Metabolism ⓘ SCIE ⓘ 2.7 GASTROENTEROLOGY & HEPATOLOGY ⓘ eiji.yoshihara@lundquist.org;evans@salk.edu;jmsuh@kaist.ac.kr; ⓘ
Greer, Phil
(Greer, P) ⓘ 		Ariel Precis Med, Pittsburgh, PA USA
Univ Pittsburgh, Dept Med, Pittsburgh, PA USA ⓘ 		GZL-2084-2022
Greer, Phil ⓘ 		0000-0003-2266-4265
Greer, Phil ⓘ 		[JCR상위 2.7] Estrogen-Related Receptor γ Maintains Pancreatic Acinar Cell Function and Identity by Regulating Cellular Metabolism ⓘ SCIE ⓘ 2.7 GASTROENTEROLOGY & HEPATOLOGY ⓘ eiji.yoshihara@lundquist.org;evans@salk.edu;jmsuh@kaist.ac.kr; ⓘ
Harbeck, Nadia
(Harbeck, N) ⓘ 		Ludwig Maximilian Univ Hosp, Breast Ctr, Dept Obstet & Gynecol, Munich, Germany
Ludwig Maximilian Univ Hosp, Comprehens Canc Ctr Munich, Munich, Germany ⓘ 		JOZ-6178-2023
Harbeck, Nadia ⓘ
ⓘ 		[JCR상위 2.7] Trastuzumab deruxtecan (T-DXd) versus treatment of physician's choice (TPC) in patients (pts) with HER2-low unresectable and/or metastatic breast cancer (mBC): Results of DESTINY-Breast04, a randomized, phase 3 study.
[JCR상위 0.9] Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer ⓘ 		SCIE ⓘ 0.9 ONCOLOGY
MEDICINE, GENERAL & INTERNAL ⓘ 		modis@mskcc.org; ⓘ
Hong, Sujung
(Hong, SJ) ⓘ 		Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 2.7] Estrogen-Related Receptor γ Maintains Pancreatic Acinar Cell Function and Identity by Regulating Cellular Metabolism ⓘ SCIE ⓘ 2.7 GASTROENTEROLOGY & HEPATOLOGY ⓘ eiji.yoshihara@lundquist.org;evans@salk.edu;jmsuh@kaist.ac.kr; ⓘ
Hwang, Hayoung
(Hwang, H) ⓘ 		Daegu Gyeongbuk Med Innovat Fdn, New Drug Dev Ctr, Daegu, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 2.7] Estrogen-Related Receptor γ Maintains Pancreatic Acinar Cell Function and Identity by Regulating Cellular Metabolism ⓘ SCIE ⓘ 2.7 GASTROENTEROLOGY & HEPATOLOGY ⓘ eiji.yoshihara@lundquist.org;evans@salk.edu;jmsuh@kaist.ac.kr; ⓘ
Jacot, William
(Jacot, W) ⓘ 		Univ Montpellier, Inst Canc Montpellier, INSERM Un 1194, Montpellier, France ⓘ
ⓘ
ⓘ 		[JCR상위 2.7] Trastuzumab deruxtecan (T-DXd) versus treatment of physician's choice (TPC) in patients (pts) with HER2-low unresectable and/or metastatic breast cancer (mBC): Results of DESTINY-Breast04, a randomized, phase 3 study.
[JCR상위 0.9] Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer ⓘ 		SCIE ⓘ 0.9 ONCOLOGY
MEDICINE, GENERAL & INTERNAL ⓘ 		modis@mskcc.org; ⓘ
페이지 이동: